<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04577131</url>
  </required_header>
  <id_info>
    <org_study_id>HM20019041</org_study_id>
    <nct_id>NCT04577131</nct_id>
  </id_info>
  <brief_title>Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support</brief_title>
  <official_title>Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to evaluate the impact of monitoring blood pressure&#xD;
      from home everyday with pharmacist support.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High blood pressure is very common and increases risk of heart, kidney, brain, and eye&#xD;
      disease. It is important to diagnose and treat high blood pressure to reduce risk of these&#xD;
      complications. Getting blood pressure checked only when someone sees a doctor is not the best&#xD;
      way to diagnose high blood pressure or to make sure blood pressure is well managed. Checking&#xD;
      blood pressure at home gives a better idea of whether someone's blood pressure is normal or&#xD;
      too high.&#xD;
&#xD;
      As part of their usual blood pressure monitoring, participants will be given an Omron 3&#xD;
      series or 5 series blood pressure monitor which has been cleared by the US Food and Drug&#xD;
      Administration and validated to meet accuracy and performance requirements. For one month,&#xD;
      participants will monitor their blood pressure once a day and then return the device to the&#xD;
      clinic at the end of the study. Participants will text their blood pressure result to the&#xD;
      American Heart Association's Check, Change, Control (CCC) secure online tracker.&#xD;
&#xD;
      As part of the research study, participants will also be randomized to either receive or not&#xD;
      receive weekly check-in phone calls from a pharmacist to review their blood pressures and the&#xD;
      number of times they tested in that week. Approximately 50 individuals will participate in&#xD;
      this study. Participation in this study will last 1 month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The tracker application has been withdrawn by developer and no other suitable tracker&#xD;
    application has been identified to replace it.&#xD;
  </why_stopped>
  <start_date type="Actual">November 5, 2020</start_date>
  <completion_date type="Actual">November 5, 2020</completion_date>
  <primary_completion_date type="Actual">November 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in adherence to home blood pressure monitoring</measure>
    <time_frame>1 month</time_frame>
    <description>Proportion of days blood pressure is measured based on data from the blood pressuring monitor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in proportion of participants with a blood pressure &lt;130/80 mm Hg.</measure>
    <time_frame>1 month</time_frame>
    <description>Proportion of participants with a blood pressure &lt;130/80 mm Hg.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>With check-ins</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily blood pressure monitoring with weekly check-ins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without check-ins</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Daily blood pressure monitoring without weekly check-ins</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Weekly check-in</intervention_name>
    <description>Weekly check-in phone calls from a pharmacist to review blood pressures and the number of times tested in that week</description>
    <arm_group_label>With check-ins</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age and older&#xD;
&#xD;
          -  Uncontrolled hypertension (BP &gt; 130/80 mm Hg)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non-English speaking patients&#xD;
&#xD;
          -  patients without a mobile phone or texting capability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dave Dixon, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 30, 2020</study_first_submitted>
  <study_first_submitted_qc>September 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

